InstaPill partners with Aché to expand access to advanced oral dispersing tablet solutions across Latin America

Bengaluru-based InstaPill has announced its strategic partnership with Brazil-based Aché Laboratórios Farmacêuticos S.A. to co-develop the first of several prescription pharmaceutical products using InstaPill’s proprietary lyophilised oral dispersing tablet (ODT) platform for the Brazilian and other Latin American markets.

Commenting on the partnership, Ankit Gupta, CEO of InstaPill, stated, “We are extremely pleased with our maiden partnership with Aché, which pairs InstaPill’s core technical capabilities in oral lyophilisates with Aché’s leading go-to-market expertise. This represents a significant step forward in our mission to expand InstaPill’s unique technology throughout Latin America.”

InstaPill is a globally recognised CDMO specialising in orally disintegrating tablets using its proprietary InstaPill® technology platform.

A leader in the prescription market in Brazil, Aché's portfolio also includes solutions in generic medicines and over-the-counter (OTC) products.